Biblio

Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is H  [Clear All Filters]
2022
Chen X, Liu Y, Zhao Y, Ouyang Z, Zhou H, Li L, Li L, Li F, Xie X, Hill RG, et al. Halide-containing bioactive glasses enhance osteogenesis in vitro and in vivo. Biomater Adv. 2022;143:213173.
Wang S, Yang X, Ai Y, Zhu Y. Haploidentical Hematopoietic Stem Cell Transplantation in a 3-Year-Old Girl with Congenital Amegakaryocytic Thrombocytopenia: A Case Report. Klin Padiatr. 2022;234(6):388-390.
Han D-M, Ding L, Zheng X-L, Yan H-M, Xue M, Liu J, Zhu L, Li S, Wang H-X. [Haploidentical Hematopoietic Stem Cell Transplantation with Co-Infusion of Mesenchymal Stromal Cells for Acquired Severe Aplastic Anemia: A Report of 127 Cases]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2022;30(4):1230-1237.
Gambella M, Bregante S, Raiola AMaria, Varaldo R, Ghiso A, Schiavetti I, Carmisciano L, Bacigalupo A, Angelucci E. Haploidentical hemopoietic cell transplantation for myelofibrosis, in ruxolitinib era. Transplant Cell Ther. 2022.
Giardino S, Bagnasco F, Falco M, Miano M, Pierri F, Risso M, Terranova P, Di Martino D, Massaccesi E, Ricci M, et al. HAPLOIDENTICAL STEM CELL TRANSPLANTATION AFTER TCR αβAND CD19 CELLS DEPLETION IN CHILDREN WITH CONGENITAL NON-MALIGNANT DISEASE. Transplant Cell Ther. 2022.
Mussetti A, Kanate AS, Wang T, He M, Hamadani M, Sr HFinel, Boumendil A, Glass B, Castagna L, Dominietto A, et al. Haploidentical versus matched unrelated donor transplants using post-transplant cyclophosphamide for lymphomas. Transplant Cell Ther. 2022.
Huang F, Zeng X, Fan Z, Xu N, Yu S, Xuan L, Liu H, Jin H, Lin R, Shi P, et al. Haplo-peripheral blood stem cell plus cord blood grafts for hematologic malignancies might lead to lower relapse compared with haplo-peripheral blood stem cell plus bone marrow grafts. Transplant Cell Ther. 2022.
Zhong Z, Feng S, Mansfeld BN, Ke Y, Qi W, Lim Y-W, Gruissem W, Bart RS, Jacobsen SE. Haplotype-resolved DNA methylome of African cassava genome. Plant Biotechnol J. 2022.
Querceto S, Santoro R, Gowran A, Grandinetti B, Pompilio G, Regnier M, Tesi C, Poggesi C, Ferrantini C, Pioner JManuel. The harder the climb the better the view: The impact of substrate stiffness on cardiomyocyte fate. J Mol Cell Cardiol. 2022.
Ren E, Chen H, Qin Z, Guan S, Jiang L, Pang X, He Y, Zhang Y, Gao X, Chu C, et al. Harnessing Bifunctional Ferritin with Kartogenin Loading for Mesenchymal Stem Cell Capture and Enhancing Chondrogenesis in Cartilage Regeneration. Adv Healthc Mater. 2022:e2101715.
Yu T-T, Peng X-C, Wang M-F, Han N, Xu H-Z, Li Q-R, Li L-G, Xu X, Ma Q-L, Liu B, et al. Harnessing chlorin e6 loaded by functionalized iron oxide nanoparticles linked with glucose for target photodynamic therapy and improving of the immunogenicity of lung cancer. J Cancer Res Clin Oncol. 2022.
Callaghan NI, Durland LJ, Ireland RG, J Santerre P, Simmons CA, Huyer LDavenport. Harnessing conserved signaling and metabolic pathways to enhance the maturation of functional engineered tissues. NPJ Regen Med. 2022;7(1):44.
Parma B, Wurdak H, Ceppi P. Harnessing mitochondrial metabolism and drug resistance in non-small cell lung cancer and beyond by blocking heat-shock proteins. Drug Resist Updat. 2022;65:100888.
Ostrowski RP, Pucko EB. Harnessing oxidative stress for anti-glioma therapy. Neurochem Int. 2022:105281.
Pavani KChaitanya, Meese T, Pascottini OBogado, Guan XF, Lin X, Peelman L, Hamacher J, Van Nieuwerburgh F, Deforce D, Boel A, et al. Hatching is modulated by microRNA-378a-3p derived from extracellular vesicles secreted by blastocysts. Proc Natl Acad Sci U S A. 2022;119(12):e2122708119.
Zhuge R, Wang C, Wang J, Yu S, Liao L, Zheng X. hCINAP regulates the differentiation of embryonic stem cells by regulating NEDD4 liquid-liquid phase-separation-mediated YAP1 activation. Cell Rep. 2022;42(1):111935.
Choi J-K, Park S, Park J-A, Shin H-E, Choi Y, Lee Y. HDAC inhibitor and proteasome inhibitor induce cleavage and exosome-mediated secretion of HSP90 in mouse pluripotent stem cells. Biochem Biophys Res Commun. 2022;620:29-34.
Valdez BC, Nieto Y, Yuan B, Murray D, Andersson BS. HDAC inhibitors suppress protein poly(ADP-ribosyl)ation and DNA repair protein levels and phosphorylation status in hematologic cancer cells: implications for their use in combination with PARP inhibitors and chemotherapeutic drugs. Oncotarget. 2022;13:1122-1135.
Pezzotta A, Gentile I, Genovese D, Totaro MGrazia, Battaglia C, Leung AYu-Hung, Fumagalli M, Parma M, Cazzaniga G, Fazio G, et al. HDAC6 inhibition decreases leukemic stem cell expansion driven by Hedgehog hyperactivation by restoring primary ciliogenesis. Pharmacol Res. 2022:106378.
Li T, Wu H, Wang P, Kim AM, Jia J, Nolta JA, Zhou P. HDACs regulate the differentiation of endothelial cells from human iPSCs. Cell Biochem Funct. 2022.
Tang E, Zaidi M, Lim W-H, Govindasamy V, Then K-Y, Then K-L, Das AKumar, Cheong S-K. Headway and the remaining hurdles of mesenchymal stem cells therapy for bronchopulmonary dysplasia. Clin Respir J. 2022.
Ahrens-Nicklas RC. Heal thyself: The promise of autologous hematopoietic stem cell gene therapy in neurometabolic disorders. Mol Ther. 2022.
Esteban-Lopez M, Perry MD, Garbinski LD, Manevski M, Andre M, Ceyhan Y, Caobi A, Paul P, Lau LSeng, Ramelow J, et al. Health effects and known pathology associated with the use of E-cigarettes. Toxicol Rep. 2022;9:1357-1368.
Lin C, Sajeev G, Stiff PJ, Brunstein CG, Cutler C, Sanz G, Lindemans CA, Rezvani AR, Hanna R, Koh LPiu, et al. Health-Related Quality of Life Following Allogeneic Hematopoietic Cell Transplantation with Omidubicel Versus Umbilical Cord Blood. Transplant Cell Ther. 2022.
Loibl S, Loirat D, Tolaney SM, Punie K, Oliveira M, Rugo HS, Bardia A, Hurvitz SA, Brufsky AM, Kalinsky K, et al. Health-related quality of life in the phase III ASCENT trial of sacituzumab govitecan versus standard chemotherapy in metastatic triple-negative breast cancer. Eur J Cancer. 2022;178:23-33.

Pages